Shinichi Matsumoto

Prof. Shinichi Matsumoto

Kobe University, Kōbe, Hyōgo, Japan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in EBioMedicine
Verified
Journal Article
Open access
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
AAAdrian Abalovich
Adrian Abalovich
CWCarlos Wechsler
Carlos Wechsler
SWShaun Wynyard
Shaun Wynyard
RERobert B. Elliott
Robert B. Elliott
Allogeneic islet transplantation has become a viable option for the treatment of unstable type 1 diabetes. However, the donor shortage and the necessity of the immunosuppressive drugs are two major issues. To solve these issues, we performed islet xenotransplantation using encapsulated neonatal porcine islets without immunosuppressive drugs. Two different doses (approximately 5000IEQ/kg and 10,000IEQ/kg) of encapsulated neonatal porcine islets were transplanted twice (total approximately 10,000IEQ/kg and 20,000IEQ/kg) into four type 1 diabetic patients in each group (total 8 patients). In the higher dose group, all four patients improved HbA1c. This was maintained at a level of 600days with significant reduction of the frequency of unaware hypoglycemic events. The clinical benefit of islet xenotransplantation with microencapsulation has been shown.

1 July 2014 in Transplantation Proceedings
Verified
Journal Article
Closed access
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
PTP. Tan
P. Tan
JBJ. Baker
J. Baker
KDK. Durbin
K. Durbin
MTM. Tomiya
M. Tomiya
RER.B. Elliott
R.B. Elliott

11 June 2016 in Journal of Diabetes
Verified
Journal Article
Closed access
PDF file
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
MTMasayuki Tomiya
Masayuki Tomiya
OSOsamu Sawamoto
Osamu Sawamoto

27 December 2006 in Transplantation
Verified
Journal Article
Closed access
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
TOTeru Okitsu
Teru Okitsu
YIYasuhiro Iwanaga
Yasuhiro Iwanaga
HNHirofumi Noguchi
Hirofumi Noguchi
HNHideo Nagata
Hideo Nagata
KTKoichi Tanaka
Koichi Tanaka
Background. Islet transplantation has become an option for the treatment of insulin-dependent diabetes mellitus and is usually performed using brain-dead heartbeating donors. However, we have very limited number of such donors in Japan; therefore, it is not allowed to perform islet transplantation with brain-dead donors. In order to perform islet transplantation in Japan, we need to seek new donor resources. Methods. We performed the first successful living-donor islet transplantation. In this case, the recipient had brittle diabetes with hypoglycemic unawareness. The donor was deemed qualified after undergoing both metabolic and preoperative assessments. Distal pancreatectomy was performed using open laparotomy and more than 400,000 islets were isolated and transplanted immediately. Results. The recipient has been insulin independent posttransplant with positive C-peptide for more than one year. She no longer suffers from hypoglycemic unawareness and displayed a substantial improvement in hemoglobulin (Hb) A1C. The donor’s clinical course was uneventful, which allowed her to return to her job within one month. She maintained normal fasting C-peptide and HbA1C levels during follow-up period. Conclusion. In our first case of living donor islet transplantation, both the donor and the recipient have been maintaining excellent glycemic control with no untreatable complications for more than one year.

1 March 2012 in Cell Transplantation
Verified
Journal Article
Open access
BNBashoo Naziruddin
Bashoo Naziruddin
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
HNHirofumi Noguchi
Hirofumi Noguchi
MTMorihito Takita
Morihito Takita
MSMasayuki Shimoda
Masayuki Shimoda
MLMarlon F. Levy
Marlon F. Levy
Total or partial pancreatectomy followed by autologous islet transplantation is a therapeutic option for the treatment of refractory chronic pancreatitis (CP). Maximization of islet yields from fibrotic and inflamed organs is crucial for prevention of posttransplant diabetes. We adapted technical advancements developed for islet allotransplantation toward islet autotransplantation. Eight patients (two men, six women; ages 24–58 years) underwent total ( n = 7) or partial ( n = 1) pancreatectomy for the treatment of CP refractory to maximal medical management. Pancreata were preserved in UW solution (UW group) in initial three cases and the last five pancreata were preserved with pancreatic ductal injection followed by ET-Kyoto/oxygenated PFC solutions (DI+TLM group). Islets were isolated by modified Ricordi method and were purified only in one case. All islet infusions were performed under general anesthesia via direct vein injection into the portal venous system with pressure monitoring. Total islet yields (129,314 ± 51,627 vs. 572,841 ± 116,934 IEQ, p < 0.04), islet yield/pancreas weight (1,233 ± 359 vs. 6,848 ± 847 IEQ/g, p < 0.003), and islet yield/patient body weight (1,951 ± 762 vs. 7,305 ± 1,531 IEQ/kg, p < 0.05) were significantly higher in the DI+TLM group when compared to the UW group. Pellet size was also higher (5.3 ± 0.3 vs. 13.5 ± 3.4 ml) in the DI+TLM group, suggesting that this method of preservation effectively protected pancreatic tissue against autolysis. First month posttransplant basal C-peptide and the secretory unit of islet transplant objects (SUITO) index were also higher in the DI+TLM group when compared to the UW group (2.0 ± 0.3 vs. 1.4 ± 0.4 ng/ml and 42.6 ± 12.7 vs. 14.6 ± 5.6, respectively). There were no technical complications related to the infusion. Our results suggest that higher islet yields can be achieved even from chronically inflamed and fibrotic organs using DI+TLM. The techniques applied for islet isolations from normal pancreata are showing promise for fibrotic pancreata from CP patients.

1 May 2009 in Cell Transplantation
Verified
Journal Article
Open access
PDF file
Shinichi MatsumotoShinichi Matsumoto
Shinichi Matsumoto
HNHirofumi Noguchi
Hirofumi Noguchi
NHNobuyo Hatanaka
Nobuyo Hatanaka
MSMasayuki Shimoda
Masayuki Shimoda
NKNaoya Kobayashi
Naoya Kobayashi
MLMarlon F. Levy
Marlon F. Levy
The quality of donor pancreata is important for successful islet isolation. However, in some countries like Japan, the number of donor pancreata is very low; therefore, marginal donors have been used with less restrictive donor criteria. In order to use marginal donor pancreata, we established the Kyoto islet isolation method (KIIM). According to United Network for Organ Sharing (UNOS) in 2005, more than 6,000 pancreata were not clinically used in the US. In this study, we applied the KIIM for brain-dead donors and reevaluated donor usability based on the Japanese islet donor criteria. Islets were isolated with the Ricordi method using pancreata stored in University of Wisconsin (UW) solution (UW group) or by the two-layer method (TLM group) or the TLM combined with ductal injection (DI group). We implemented the KIIM (KIIM group) to confirm the effect of the KIIM on brain-dead donors. Donor charts in Texas from 2005 to 2006 were reviewed. If pancreata were not used clinically, the reason was reviewed and donors were reevaluated based on Japanese criteria. There were no significant differences of islet yield, viability, and purity between the UW and TLM groups. The DI group significantly improved islet yields and isolations were further improved in the KIIM group [UW: 251,663 ± 60,217 islet equivalent (IE); TLM: 243,738 ± 54,170 IE; DI: 498,639 ± 28,853 IE; KIIM: 678,286 ± 55,853]. The KIIM provided high-quality islets in high numbers from islet isolations from brain-dead donors. A total of 236 donor charts were reviewed and 194 pancreata (82%) were not used. Of these, 185 cases identified the reasons that the pancreata were not used. When we applied the Japanese criteria, an additional 82 cases out of 185 (44%) seem to be suitable for islet isolations. With the KIIM, more than 2,500 additional donor pancreata can be used for islet isolation in the US every year when the Japanese criteria are applied.